Sinecatechins Patent Expiration

Sinecatechins is Used for treating genital warts. It was first introduced by Ani Pharmaceuticals Inc in its drug Veregen on Oct 31, 2006.


Sinecatechins Patents

Given below is the list of patents protecting Sinecatechins, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Veregen US7858662 Medicament for the treatment of viral skin and tumour diseases Oct 02, 2026 Ani Pharms
Veregen US9770406 Medicament for the treatment of viral skin and tumour diseases Jul 12, 2025 Ani Pharms
Veregen US10434059 Medicament for the treatment of viral skin and tumour diseases Nov 18, 2022

(Expired)

Ani Pharms
Veregen US5795911 Composition for treating Condyloma acuminata Oct 31, 2020

(Expired)

Ani Pharms
Veregen US5968973 Method for treating hyperplasia Apr 10, 2017

(Expired)

Ani Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sinecatechins's patents.

Given below is the list recent legal activities going on the following patents of Sinecatechins.

Activity Date Patent Number
Patent litigations
Expire Patent 13 Nov, 2023 US10434059
Maintenance Fee Reminder Mailed 29 May, 2023 US10434059
Expire Patent 30 Jan, 2023 US7858662
Maintenance Fee Reminder Mailed 15 Aug, 2022 US7858662
Surcharge for Late Payment, Large Entity 14 Jul, 2021 US9770406
Payment of Maintenance Fee, 4th Year, Large Entity 14 Jul, 2021 US9770406
Maintenance Fee Reminder Mailed 17 May, 2021 US9770406
Recordation of Patent Grant Mailed 08 Oct, 2019 US10434059
Patent Issue Date Used in PTA Calculation 08 Oct, 2019 US10434059
Email Notification 19 Sep, 2019 US10434059


Sinecatechins's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List